{"id":"W4401876847","doi":"10.1016/s2152-2650(24)00857-7","title":"Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients With Relapsed and/or Refractory Follicular Lymphoma After ≥2 Prior Therapies: 3-Year Follow-Up From a Pivotal Phase II Study","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Follicular phase; Oncology; Internal medicine; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002103304,0.0007306315,0.001977327,0.0002978494,0.0005100328,0.001426482,0.0004850564,0.0008174042,0.001694171],"category_scores_gemma":[0.001140238,0.0002502574,0.001350951,0.0003864797,0.0005129402,0.001006974,0.0002594814,0.002098538,0.0006795957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000866679,"about_ca_system_score_gemma":0.0007658128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008609647,"about_ca_topic_score_gemma":0.002973662,"domain_scores_codex":[0.9994671,0.0001553228,0.00003655059,0.00007938159,0.00007847876,0.0001831193],"domain_scores_gemma":[0.999033,0.0002155969,0.0002357052,0.0001047373,0.00009456397,0.0003164642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.23321,0.01498467,0.07312149,0.001366948,0.006355383,0.0008456725,0.000650938,0.003244113,0.08958171,0.0004900528,0.01739202,0.5587569],"study_design_scores_gemma":[0.1806756,0.3211673,0.4279869,0.0003506539,0.005598109,0.002927095,0.000449728,0.003654473,0.01860757,0.0009279437,0.03750417,0.0001504062],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853339,0.009810698,0.0003628821,0.0007357851,0.0001057551,0.0002687975,0.0009780612,0.00008473879,0.002319437],"genre_scores_gemma":[0.9925572,0.002445584,0.0003984997,0.001134656,0.0001110137,0.0001615769,0.001989442,0.00002485767,0.001177159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002103304,"threshold_uncertainty_score":0.01112342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01896423923185216,"score_gpt":0.3125542948185412,"score_spread":0.2935900555866891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}